{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"46.180","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"123,124,800","primaryexch":"香港交易所","ric":"3347.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.4694,"inline_upper_strike_price":"","sedol":"BMZC7F8","am":"110.11","iv":"","ew_strike":"","as":"44.680","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"44.660","registrar":"卓佳證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"22.300","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"葉小平","underlying_ric":"300347.SZ","hi52":"60.600","issuer_name":"杭州泰格醫藥科技股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"0.73","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"44.560","mkt_cap":"5.49","f_aum_hkd":null,"ew_sub_per_to":"","ls":"44.660","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-2.400","aum":"","issued_shares_class_B":null,"vo":"2.44","secondary_listing_flag":false,"listing_date":"2020年8月7日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"杭州泰格醫藥科技股份有限公司 - H股","nm_s":"泰格醫藥","sym":"3347","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"杭州泰格醫藥科技股份有限公司是一家從事為新藥研發提供臨床試驗服務的中國控股公司。該公司經營兩個分部。臨床試驗技術服務分部向生物製藥和醫療器械公司提供臨床試驗運作服務和醫學翻譯等服務，幫助其進行創新藥物、仿製藥和醫療器械的臨床試驗。臨床試驗相關服務及實驗室服務分部從事提供分析服務，比如數據管理和統計分析；後勤和執行支持服務，比如臨床試驗現場管理；行政協助，比如患者招募；以及諮詢服務等。該分部同時通過其子公司為臨床前和臨床開發階段提供實驗室服務。該公司在國內市場和海外市場開展業務。","op":"45.800","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國杭州市濱江區<br/>江南大道618號<br/>東冠大廈15層<br/>郵編：310053","pc":"-5.10","days_to_expiry":null,"underlying_code":null,"pe":"90.00","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"47.060","isin":"CNE1000040M1","moneyness":""}},"qid":"1759074145120"}
